Healthcare-focused investment bank Cain Brothers has hired John Soden as a managing director. Prior to joining Cain Brothers, Soden was the managing director and head of medical technologies at Houlihan Lokey.
Cain Brothers, a pre-eminent investment bank focused exclusively on healthcare, has announced that John Soden has joined as a Managing Director in the Firm’s San Francisco office. Mr. Soden focuses on medical devices and products, life science tools, diagnostics and specialty labs.
Mr. Soden brings over 20 years of investment banking experience to the Cain Brothers team with a primary focus on private and public company M&A. He previously served since 2010 as Managing Director & Head of Medical Technologies at Houlihan Lokey. Mr. Soden’s recent transactions include the sales of Hygiena to Warburg Pincus, Galil Medical to BTG Plc, CORPAK MedSystems (owned by Linden Capital) to Halyard Health, Cord Blood Registry (owned by GTCR) to AMAG Pharmaceuticals, Ivera Medical to 3M and Integrated Medical Systems (IMS) to Steris. Notable restructuring experience includes creditor representations with respect to Ameritox and Angiotech Pharmaceuticals. Prior to Houlihan Lokey, Mr. Soden worked for six years in the Healthcare Group at Thomas Weisel Partners, most recently as a Managing Director, and for five years at UBS, serving as a Director in both the M&A and Healthcare groups.
Rob Fraiman, President & CEO of Cain Brothers commented: “John Soden is an outstanding investment banker who brings a broad and deep base of execution and industry experience to our medtech and life sciences team. John’s experience and relationships complement those of Rafe Hanahan who joined us in early 2015 to initiate our medtech effort, Kristin Carey who joined us earlier this year to focus on pharmaceutical services and specialty pharma companies and Vice Chairman David Hetz who has extensive relevant sector experience as an investment banker and private equity investor.”
Mr. Soden said: “I am very excited to join a dedicated healthcare firm that can offer a fully integrated perspective of how medical technologies fit strategically within the rapidly evolving universe of payers and providers. I look forward to working with Rafe, Kristin, David and the rest of the Cain Brothers team of 75 dedicated professionals to bring our clients creative ideas, unique macro perspectives and outstanding senior-level execution.”
Rafe Hanahan added, “John is a terrific addition to our expanding team of highly capable bankers covering medtech, life sciences and healthcare services.”
Cain Brothers is a pre-eminent investment bank focused exclusively on healthcare. We deliver innovative solutions and fresh ideas to our mergers & acquisitions, capital raising, and strategic and financial advisory clients from our offices across the country. Our deep knowledge of the industry is matched with the knowhow needed to efficiently execute the most complex transactions of all sizes. With our exclusive focus on healthcare, we have an unobstructed view of this rapidly evolving industry that enables us to provide unique perspectives to our clients. www.cainbrothers.com